HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
about
Pulmonary epithelial barrier function: some new players and mechanismsHuman epidermal growth factor receptor signaling in acute lung injuryComplete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 cases.MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.Effective anti-neu-initiated antitumor responses require the complex role of CD4+ T cells.Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals.HER2 assessment by silver in situ hybridization: where are we now?Combination cancer immunotherapies tailored to the tumour microenvironment.Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.Tau proteins expressions in advanced breast cancer and its significance in taxane-containing neoadjuvant chemotherapy.Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging.
P2860
Q26865861-8D5189DF-1282-4212-8DCE-180932111479Q27002075-6A6B234C-C2C3-492C-998D-1B502AC9E69FQ34032559-34F2ACC9-3D7D-4947-8EE5-A37119B175A7Q34855870-A1B53B97-CC9C-44F8-BD10-619B1CE34481Q36545717-B553CD00-B76E-4205-B331-DC4743B2F0F0Q36698273-D69BDEAD-E7A8-4431-8A4F-87CA39F62DF5Q37301332-0C3CB136-47D0-420E-85AB-465E756B29E4Q38314355-84F29B6F-1F1C-48B0-839C-63582180F279Q38645178-00883663-6568-437C-B904-2D0292AA27BDQ44844636-E6C8D386-1745-4F1E-A994-39E1CEF8BEF4Q46881099-8DDB6377-5754-423A-B0A0-4F32EAF6CF18Q47197599-A70EB81E-D029-4965-B80A-490A323F3837
P2860
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
@en
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
@nl
type
label
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
@en
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
@nl
prefLabel
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
@en
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
@nl
P2093
P1476
HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
@en
P2093
Christos Sotiriou
Lina Pugliano
Martine J Piccart
P304
P356
10.1097/CCO.0B013E32834BD4C9
P577
2011-11-01T00:00:00Z